Executive Summary
This overnight filing cycle is dominated by a major M&A development in the protein sector, with JBS N.V. making a non-binding proposal to acquire the remaining ~18% of Pilgrim's Pride it does not own. The implied valuation offers no premium, creating a potential arbitrage opportunity but also signaling a lack of urgency from the buyer.
Insider selling is the most prevalent theme, with notable disposals from executives at Roivant Sciences, Corpay, and Veradermics, suggesting management is taking profits at elevated levels. A significant governance battle is unfolding at Better Home & Finance, where the CEO's attempt to remove directors has led to a lawsuit, creating high uncertainty. On the positive side, a key regulatory condition (HSR waiting period) was cleared for argenx's acquisition of Forte Biosciences, moving that deal closer to completion. The filing set also includes a delisting notice for Skye Bioscience due to negative equity, and a large convertible note issuance by Datavault AI, indicating financial distress. Overall, the market is presented with a mix of high-stakes M&A, insider profit-taking, and corporate governance risks, with few clear bullish signals from operational results.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4 · Schedule 13D · Schedule 13G · 8-K
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from August 12, 2026.
Investment Signals (12)
- Pilgrim's Pride (PPC) (BEARISH)▲
JBS offers 2.086 JBS shares per PPC share, implying ~$28.49 value with no premium to market. The 82.1% holder is offering a non-binding deal with no premium, suggesting limited upside for minority holders unless a special committee extracts better terms.
- Roivant Sciences ↓ (BEARISH)▲
President & CIO sold ~$10.3M worth of shares at $36.25, after exercising options at $3.85. This massive insider profit-taking at a 9x gain signals management believes the stock is fully valued.
- Corpay (CPAY) (BEARISH)▲
Group President King Alan sold ~$3.94M in stock, with 14 transactions reported. The scale of selling by a key divisional head is a strong signal of insider bearishness.
- Veradermics ↓ (BEARISH)▲
CEO sold ~$2.98M and CTO sold ~$1.82M in stock at ~$108, both under 10b5-1 plans. While pre-planned, the magnitude of sales relative to holdings is significant, suggesting a top.
- Ascendis Pharma (ASND) (BULLISH)▲
Director Bienaime bought ~$270K worth of shares at ~$246, a rare insider purchase in the biotech sector. This signals strong conviction from a board member.
- Forte Biosciences (FBRX) (BULLISH)▲
HSR waiting period for argenx's $77/share tender offer expired, clearing a key condition. The deal is on track, offering a clear arbitrage opportunity.
- Kenon Holdings (KEN) (BULLISH)▲
Received ~$93M from an arbitration award against Peru. This is a significant, unexpected cash windfall that could be used for special dividends or buybacks.
- Equinor (EQNR) (BULLISH)▲
Continued its buyback program, repurchasing 415,000 shares at an average price of NOK 382.8. The aggressive buyback at elevated prices signals management's confidence in intrinsic value.
- Duolingo (DUOL) (BULLISH)▲
Inadvertently disclosed a 27.4% DAU growth rate for August 17, 2026. While preliminary, this suggests strong Q3 momentum, potentially beating guidance.
- Meta Platforms (META) (NEUTRAL)▲
Multiple executives (CFO, CAO, CPO) had shares withheld for taxes, a routine process. However, CFO Li Susan J also sold 2,127 shares at $689.85, a small but notable direct sale.
- Icahn Enterprises (IEP) (BULLISH)▲
CEO awarded 33,242 Deferred Depositary Units, a large equity grant that aligns management with long-term performance.
- Ralph Lauren (RL) (BULLISH)▲
CEO Louvet Patrice had 7,875 shares withheld for taxes, but was awarded 23,241 new shares. The net increase in holdings is a positive signal.
Risk Flags (10)
- Skye Bioscience (SKYE) [HIGH RISK]▼
Received Nasdaq delisting notice due to negative stockholders' equity of -$497K, well below the $2.5M minimum. Has 45 days to submit a plan; delisting risk is very high.
- Better Home & Finance (BETR) [HIGH RISK]▼
CEO Vishal Garg is in a legal battle with the company after a failed attempt to remove directors. The company sued him for SEC violations, creating severe governance instability.
- Datavault AI (DVA) [HIGH RISK]▼
Issued a $25.03M convertible promissory note with onerous covenants, including restrictions on further issuances. This is a distressed financing that could lead to significant dilution.
- Roivant Sciences↓ [MODERATE RISK]▼
President & CIO sold 284,707 shares, representing a significant portion of his exercisable holdings. This is a major vote of no confidence from a top insider.
- Corpay (CPAY) [MODERATE RISK]▼
Group President King Alan sold 9,600 shares, reducing his stake materially. The sale of a key divisional leader's stock is a red flag for future performance.
- Veradermics↓ [MODERATE RISK]▼
Both CEO and CTO sold large blocks of stock in the same filing period. This coordinated insider selling is a strong bearish signal.
- TEEKAY TANKERS (TNK) [MODERATE RISK]▼
Managing Director sold 6,375 shares at $89.28. Insider selling in a cyclical shipping company near peak earnings is a classic sell signal.
- Pilgrim's Pride (PPC) [MODERATE RISK]▼
JBS's non-binding proposal offers no premium, implying the majority owner sees no urgency to pay up. This could signal a lack of competing bids and limited upside.
- First Choice Healthcare (FCHS) [MODERATE RISK]▼
The $21.3M acquisition is contingent on a separate business combination with Westin, which has not closed. The deal faces multiple conditions and regulatory hurdles.
- Exponent (EXPO) [LOW RISK]▼
CEO sold 1,707 shares under a 10b5-1 plan. While small, any CEO sale is worth monitoring.
Opportunities (10)
- Forte Biosciences (FBRX) / argenx Tender (OPPORTUNITY)◆
HSR clearance removes a key deal condition. With the $77/share offer likely to close, the stock should trade near that level, offering a low-risk arbitrage.
- Ascendis Pharma (ASND) / Insider Buying (OPPORTUNITY)◆
Director bought ~$270K at ~$246. This is a rare insider purchase in biotech, suggesting the stock is undervalued.
- Kenon Holdings (KEN) / Cash Windfall (OPPORTUNITY)◆
The $93M arbitration award is a significant catalyst. The company could use the cash for a special dividend, buyback, or new investment.
- Duolingo (DUOL) / DAU Growth (OPPORTUNITY)◆
The inadvertent disclosure of 27.4% DAU growth suggests Q3 is off to a strong start. If this trend continues, the company could raise guidance.
- Equinor (EQNR) / Buyback (OPPORTUNITY)◆
The aggressive buyback at NOK 382.8 signals management's confidence. Investors can ride the buyback tailwind.
- Icahn Enterprises (IEP) / CEO Grant (OPPORTUNITY)◆
The large deferred unit award to the CEO aligns incentives. This could signal upcoming value-creation initiatives.
- Pilgrim's Pride (PPC) / M&A Arbitrage (OPPORTUNITY)◆
If a special committee can negotiate a better exchange ratio or a competing bid emerges, the stock could see upside. The current no-premium offer creates a floor.
- Ralph Lauren (RL) / Insider Accumulation (OPPORTUNITY)◆
CEO's net share increase after tax withholding suggests confidence. The stock has been a strong performer, and insider behavior supports the trend.
- ZTO Express (ZTO) / Q2 Results (OPPORTUNITY)◆
The company reported Q2 2026 results. If the numbers show strong volume growth and margin improvement, it could be a buying opportunity in the logistics sector.
- Weibo (WB) / Q2 Results (OPPORTUNITY)◆
The company reported Q2 2026 results. If the numbers show a recovery in advertising revenue, it could be a turnaround play.
Sector Themes (6)
- Protein Sector Consolidation◆
JBS's bid for Pilgrim's Pride is a major move in the protein sector. The no-premium offer suggests a buyer's market, but it could spark consolidation among other poultry and meat processors. [IMPLICATION: Watch for follow-on M&A in the sector.]
- Insider Profit-Taking at High Valuations◆
A cluster of insider sales (Roivant, Corpay, Veradermics, Teekay Tankers) indicates management is taking profits at elevated levels. This is a common pattern near market or sector peaks. [IMPLICATION: Be cautious on high-growth names with recent insider selling.]
- Biotech M&A Momentum◆
The Forte Biosciences deal clearing HSR and the Ascendis insider buy suggest continued M&A and confidence in the biotech sector. [IMPLICATION: Look for other biotech companies with upcoming catalysts or potential takeout targets.]
- Governance and Legal Risks on the Rise◆
The Better Home & Finance CEO lawsuit and the Skye Bioscience delisting notice highlight increasing governance and financial distress risks. [IMPLICATION: Screen for companies with weak balance sheets or activist situations.]
- Chinese ADR Earnings Season◆
A wave of Chinese ADRs (ZTO, Weibo, iQIYI, Kingsoft Cloud) filed 6-Ks for Q2 results. The market will be looking for signs of recovery in the Chinese economy. [IMPLICATION: Positive results could trigger a sector-wide rally.]
- Distressed Financing via Convertibles◆
Datavault AI's $25M convertible note with restrictive covenants is a sign of a company in distress. This pattern may be seen more frequently as small-cap companies struggle to access traditional capital. [IMPLICATION: Avoid companies with similar financing structures.]
Watch List (8)
- Pilgrim's Pride (PPC)👁
Watch for the formation of a special committee and any counter-proposals. The stock's reaction to the no-premium offer will be key. [Date: Ongoing]
- Better Home & Finance (BETR)👁
Monitor the lawsuit and the preliminary consent statement. The outcome of the proxy fight will determine the company's future. [Date: Ongoing]
- Skye Bioscience (SKYE)👁
Watch for the submission of a compliance plan to Nasdaq by October 2, 2026. The acquisition of Redx Pharma may be part of the plan. [Date: October 2, 2026]
- Forte Biosciences (FBRX)👁
Monitor the tender offer process. The deal is expected to close soon, providing a clear arbitrage opportunity. [Date: Tender offer closing]
- Duolingo (DUOL)👁
Watch for Q3 2026 guidance or any further disclosures. The 27.4% DAU growth rate, if sustained, could lead to an earnings beat. [Date: Q3 2026 earnings]
-
Monitor for further insider selling. The President & CIO's large sale could be followed by others. [Date: Ongoing]
-
Watch for additional insider sales. The CEO and CTO's coordinated selling is a red flag. [Date: Ongoing]
-
The full exercise of the underwriters' option for additional ADSs closed on August 19, 2026. Watch for the use of proceeds and any impact on the stock price. [Date: August 19, 2026]
Filing Analyses
(50)
18-08-2026
President & CIO Sukhatme Mayukh sold 284,707 Common Shares at $36.25 (~$10.3M). 11 transactions reported in total. Sukhatme Mayukh holds 18,630,739 shares after the transaction.
- · President & CIO Sukhatme Mayukh exercised/converted 243,177 Common Shares at $3.85 (~$936K)
- · President & CIO Sukhatme Mayukh sold 243,177 Common Shares at $36.23 (~$8.81M)
- · President & CIO Sukhatme Mayukh exercised/converted 284,707 Common Shares at $3.85 (~$1.1M)
- · President & CIO Sukhatme Mayukh sold 284,707 Common Shares at $36.25 (~$10.3M)
- · President & CIO Sukhatme Mayukh exercised/converted 105,141 Common Shares at $3.85 (~$405K)
- · President & CIO Sukhatme Mayukh sold 105,141 Common Shares at $36.59 (~$3.85M)
- · President & CIO Sukhatme Mayukh exercised/converted 31,801 Common Shares at $3.85 (~$122K)
- · President & CIO Sukhatme Mayukh sold 31,801 Common Shares at $37.18 (~$1.18M)
18-08-2026
Director White Dana exercised/converted 110 Class A Common Stock. White Dana holds 1,504 shares after the transaction.
- · Director White Dana exercised/converted 110 Class A Common Stock
- · Director White Dana exercised/converted 110 Restricted Stock Units (RSU) (Class A)
18-08-2026
Director Arnold John Douglas exercised/converted 167 Class A Common Stock. Arnold John Douglas holds 3,329 shares after the transaction.
- · Director Arnold John Douglas exercised/converted 167 Class A Common Stock
- · Director Arnold John Douglas exercised/converted 167 Restricted Stock Units (RSU) (Class A)
18-08-2026
Director Elkann John had withheld for taxes 8 Class A Common Stock at $589.85 (~$4.72K). Elkann John holds 1,445 shares after the transaction.
- · Director Elkann John exercised/converted 110 Class A Common Stock
- · Director Elkann John had withheld for taxes 8 Class A Common Stock at $589.85 (~$4.72K)
- · Director Elkann John exercised/converted 110 Restricted Stock Units (RSU) (Class A)
18-08-2026
Managing Director, Sinagpore Kapoor Rohit (RK2) sold 6,375 Class A Common Shares at $89.28 (~$569K). Kapoor Rohit (RK2) holds 2,126.4877 shares after the transaction.
- · Managing Director, Sinagpore Kapoor Rohit (RK2) sold 6,375 Class A Common Shares at $89.28 (~$569K)
18-08-2026
GroupPresident IntlVehiclePmts King Alan sold 9,600 Common Stock at $410.00 (~$3.94M). 14 transactions reported in total. King Alan holds 24,537 shares after the transaction.
- · GroupPresident IntlVehiclePmts King Alan exercised/converted 7,122 Common Stock at $261.07 (~$1.86M)
- · GroupPresident IntlVehiclePmts King Alan sold 7,122 Common Stock at $419.58 (~$2.99M)
- · GroupPresident IntlVehiclePmts King Alan exercised/converted 6,600 Common Stock at $261.07 (~$1.72M)
- · GroupPresident IntlVehiclePmts King Alan sold 183 Common Stock at $410.09 (~$75K)
- · GroupPresident IntlVehiclePmts King Alan sold 2,617 Common Stock at $410.88 (~$1.08M)
- · GroupPresident IntlVehiclePmts King Alan sold 3,800 Common Stock at $412.10 (~$1.57M)
- · GroupPresident IntlVehiclePmts King Alan exercised/converted 9,600 Common Stock at $231.70 (~$2.22M)
- · GroupPresident IntlVehiclePmts King Alan sold 9,600 Common Stock at $410.00 (~$3.94M)
18-08-2026
Chief Financial Officer LI SUSAN J had withheld for taxes 6,922 Class A Common Stock at $589.85 (~$4.08M). 14 transactions reported in total. LI SUSAN J holds 22,382 shares after the transaction.
- · Chief Financial Officer LI SUSAN J exercised/converted 2,400 Class A Common Stock
- · Chief Financial Officer LI SUSAN J exercised/converted 1,888 Class A Common Stock
- · Chief Financial Officer LI SUSAN J sold 2,127 Class A Common Stock at $689.85 (~$1.47M)
- · Chief Financial Officer LI SUSAN J exercised/converted 6,791 Class A Common Stock
- · Chief Financial Officer LI SUSAN J exercised/converted 2,679 Class A Common Stock
- · Chief Financial Officer LI SUSAN J exercised/converted 1,783 Class A Common Stock
- · Chief Financial Officer LI SUSAN J exercised/converted 2,704 Class A Common Stock
- · Chief Financial Officer LI SUSAN J had withheld for taxes 6,922 Class A Common Stock at $589.85 (~$4.08M)
18-08-2026
Chief Accounting Officer Anderson Aaron had withheld for taxes 1,216 Class A Common Stock at $589.85 (~$717K). 9 transactions reported in total. Anderson Aaron holds 9,511 shares after the transaction.
- · Chief Accounting Officer Anderson Aaron exercised/converted 1,450 Class A Common Stock
- · Chief Accounting Officer Anderson Aaron exercised/converted 332 Class A Common Stock
- · Chief Accounting Officer Anderson Aaron exercised/converted 331 Class A Common Stock
- · Chief Accounting Officer Anderson Aaron exercised/converted 335 Class A Common Stock
- · Chief Accounting Officer Anderson Aaron had withheld for taxes 1,216 Class A Common Stock at $589.85 (~$717K)
- · Chief Accounting Officer Anderson Aaron exercised/converted 1,450 Restricted Stock Units (RSU) (Class A)
- · Chief Accounting Officer Anderson Aaron exercised/converted 332 Restricted Stock Units (RSU) (Class A)
- · Chief Accounting Officer Anderson Aaron exercised/converted 331 Restricted Stock Units (RSU) (Class A)
18-08-2026
Chief Product Officer Cox Christopher K had withheld for taxes 8,127 Class A Common Stock at $589.85 (~$4.79M). 9 transactions reported in total. Cox Christopher K holds 264,516 shares after the transaction.
- · Chief Product Officer Cox Christopher K exercised/converted 6,791 Class A Common Stock
- · Chief Product Officer Cox Christopher K exercised/converted 2,679 Class A Common Stock
- · Chief Product Officer Cox Christopher K exercised/converted 1,960 Class A Common Stock
- · Chief Product Officer Cox Christopher K exercised/converted 4,958 Class A Common Stock
- · Chief Product Officer Cox Christopher K had withheld for taxes 8,127 Class A Common Stock at $589.85 (~$4.79M)
- · Chief Product Officer Cox Christopher K exercised/converted 6,791 Restricted Stock Units (RSU) (Class A)
- · Chief Product Officer Cox Christopher K exercised/converted 2,679 Restricted Stock Units (RSU) (Class A)
- · Chief Product Officer Cox Christopher K exercised/converted 1,960 Restricted Stock Units (RSU) (Class A)
18-08-2026
Paine Schwartz Food Chain Fund V GP, Ltd. filed a Schedule 13D with the SEC on August 18, 2026, disclosing beneficial ownership of 24,245,169 shares of Suja Life, Inc. Class A common stock, representing 62.77% of the outstanding shares. The filing was triggered by open market purchases of 920,641 shares between August 10 and August 18, 2026, for an aggregate of $5,924,881.39, which caused the reporting person to lose eligibility to file on Schedule 13G. The Paine Schwartz entities hold a majority of the board through a Director Designation Agreement and have the right to nominate a majority of directors as long as they own at least 40% of outstanding common stock.
- · The reporting person initially filed a Schedule 13G on August 11, 2026, but converted to Schedule 13D after open market purchases exceeded the threshold for passive investor status.
- · The open market purchases were executed by PSP Suja Life Aggregator, L.P., an entity indirectly controlled by the reporting person.
- · The beneficial ownership calculation includes 14,836,312 shares of Class A common stock issuable upon exchange of LP Units and an equal number of Class V common stock shares.
- · The reporting person and its affiliates may seek to increase or decrease their position, engage in hedging transactions, or communicate with the board and management regarding strategic alternatives.
- · A lock-up agreement restricts transfer of shares by the Lock-Up Parties for 180 days from May 6, 2026 (expiring approximately November 2, 2026), subject to customary exceptions.
- · The Director Designation Agreement grants Paine Schwartz the right to nominate a majority of directors as long as it owns at least 40% of outstanding common stock.
18-08-2026
JBS N.V. has made a non-binding proposal to acquire all outstanding shares of Pilgrim's Pride Corp (PPC) not already owned by JBS or its affiliates, offering a fixed exchange ratio of 2.086 JBS Class A common shares per PPC share. The proposal, delivered on August 18, 2026, is subject to the formation of a special committee of independent directors to evaluate it. The filing is an amendment to Schedule 13D, reflecting that the JBS/J&F group collectively holds 82.1% of PPC's common stock.
- · The proposal is non-binding and subject to the evaluation of a special committee of independent directors of Pilgrim's Pride.
- · The Reporting Persons include a chain of entities ultimately controlled by J&F S.A., which is owned 100% by Wesley and Joesley Mendonca Batista.
- · The filing is Amendment No. 11 to the original Schedule 13D filed on January 7, 2010.
- · JBS Wisconsin Properties, LLC directly holds the PPC shares on behalf of the group.
18-08-2026
Chief Technical Officer Durso Timothy August sold 16,767 Common Stock at $108.38 (~$1.82M). 7 transactions reported in total. Durso Timothy August holds 78,142 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Technical Officer Durso Timothy August exercised/converted 3,452 Common Stock at $12.19 (~$42.1K)
- · Chief Technical Officer Durso Timothy August sold 7,918 Common Stock at $106.71 (~$845K)
- · Chief Technical Officer Durso Timothy August sold 16,306 Common Stock at $107.52 (~$1.75M)
- · Chief Technical Officer Durso Timothy August sold 16,767 Common Stock at $108.38 (~$1.82M)
- · Chief Technical Officer Durso Timothy August sold 2,348 Common Stock at $109.34 (~$257K)
- · Chief Technical Officer Durso Timothy August sold 161 Common Stock at $111.28 (~$17.9K)
- · Chief Technical Officer Durso Timothy August exercised/converted 3,452 Stock Option (Right to Buy)
18-08-2026
Vice Chair, Chief Innovation Lauren David R. had withheld for taxes 769 Class A Common Stock at $387.23 (~$298K). 4 transactions reported in total. Lauren David R. holds 14,243 shares after the transaction.
- · Vice Chair, Chief Innovation Lauren David R. was awarded 1,548 Class A Common Stock
- · Vice Chair, Chief Innovation Lauren David R. had withheld for taxes 769 Class A Common Stock at $387.23 (~$298K)
- · Vice Chair, Chief Innovation Lauren David R. had withheld for taxes 560 Class A Common Stock at $387.23 (~$217K)
- · Vice Chair, Chief Innovation Lauren David R. had withheld for taxes 382 Class A Common Stock at $387.23 (~$148K)
18-08-2026
Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.
18-08-2026
President and Vice Chairman Powell Dina H. had withheld for taxes 3,518 Class A Common Stock at $589.85 (~$2.08M). 5 transactions reported in total. Powell Dina H. holds 10,826 shares after the transaction.
- · President and Vice Chairman Powell Dina H. exercised/converted 2,024 Class A Common Stock
- · President and Vice Chairman Powell Dina H. exercised/converted 5,708 Class A Common Stock
- · President and Vice Chairman Powell Dina H. had withheld for taxes 3,518 Class A Common Stock at $589.85 (~$2.08M)
- · President and Vice Chairman Powell Dina H. exercised/converted 2,024 Restricted Stock Units (RSU) (Class A)
- · President and Vice Chairman Powell Dina H. exercised/converted 5,708 Restricted Stock Units (RSU) (Class A)
18-08-2026
Chief Executive Officer Waldman Reid Alexander sold 27,490 Common Stock at $108.45 (~$2.98M). 7 transactions reported in total. Waldman Reid Alexander holds 170,824 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Executive Officer Waldman Reid Alexander exercised/converted 3,452 Common Stock at $12.19 (~$42.1K)
- · Chief Executive Officer Waldman Reid Alexander sold 11,527 Common Stock at $106.72 (~$1.23M)
- · Chief Executive Officer Waldman Reid Alexander sold 25,234 Common Stock at $107.53 (~$2.71M)
- · Chief Executive Officer Waldman Reid Alexander sold 27,490 Common Stock at $108.45 (~$2.98M)
- · Chief Executive Officer Waldman Reid Alexander sold 3,000 Common Stock at $109.38 (~$328K)
- · Chief Executive Officer Waldman Reid Alexander sold 249 Common Stock at $111.28 (~$27.7K)
- · Chief Executive Officer Waldman Reid Alexander exercised/converted 3,452 Stock Option (Right to Buy)
18-08-2026
PRESIDENT & CEO Forbes Alexandria sold 62,000 Ordinary Shares at $13.86 (~$859K). Forbes Alexandria holds 1,325,695 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · PRESIDENT & CEO Forbes Alexandria sold 62,000 Ordinary Shares at $13.86 (~$859K)
18-08-2026
Director BIENAIME JEAN JACQUES bought 1,100 Ordinary Shares at $245.85 (~$270K). BIENAIME JEAN JACQUES holds 2,900 shares after the transaction.
- · Director BIENAIME JEAN JACQUES bought 1,100 Ordinary Shares at $245.85 (~$270K)
- · Director BIENAIME JEAN JACQUES bought 900 Ordinary Shares at $246.91 (~$222K)
18-08-2026
10% owner Magnetar Financial LLC sold 84,544 Class A Common Stock at $108.48 (~$9.17M). This amends a previously filed Form 4. 24 transactions reported in total. Magnetar Financial LLC holds 1,328,730 shares after the transaction.
- · 10% owner Magnetar Financial LLC sold 24,708 Class A Common Stock at $108.48 (~$2.68M)
- · 10% owner Magnetar Financial LLC sold 4,912 Class A Common Stock at $109.99 (~$540K)
- · 10% owner Magnetar Financial LLC sold 552 Class A Common Stock at $110.00 (~$60.7K)
- · 10% owner Magnetar Financial LLC sold 24,743 Class A Common Stock at $108.48 (~$2.68M)
- · 10% owner Magnetar Financial LLC sold 4,919 Class A Common Stock at $109.99 (~$541K)
- · 10% owner Magnetar Financial LLC sold 553 Class A Common Stock at $110.00 (~$60.8K)
- · 10% owner Magnetar Financial LLC sold 84,544 Class A Common Stock at $108.48 (~$9.17M)
- · 10% owner Magnetar Financial LLC sold 16,807 Class A Common Stock at $109.99 (~$1.85M)
18-08-2026
Chief Financial Officer Picicci Justin M. had withheld for taxes 1,192 Class A Common Stock at $387.23 (~$462K). 4 transactions reported in total. Picicci Justin M. holds 11,261 shares after the transaction.
- · Chief Financial Officer Picicci Justin M. was awarded 1,938 Class A Common Stock
- · Chief Financial Officer Picicci Justin M. had withheld for taxes 1,192 Class A Common Stock at $387.23 (~$462K)
- · Chief Financial Officer Picicci Justin M. had withheld for taxes 671 Class A Common Stock at $387.23 (~$260K)
- · Chief Financial Officer Picicci Justin M. had withheld for taxes 382 Class A Common Stock at $387.23 (~$148K)
18-08-2026
Director de Gelder Neil was awarded 8,032 Common stock, $0.0001 par value. de Gelder Neil holds 69,168 shares after the transaction.
- · Director de Gelder Neil was awarded 8,032 Common stock, $0.0001 par value
18-08-2026
President and CEO Louvet Patrice had withheld for taxes 7,875 Class A Common Stock at $387.23 (~$3.05M). 6 transactions reported in total. Louvet Patrice holds 129,485 shares after the transaction.
- · President and CEO Louvet Patrice was awarded 23,241 Class A Common Stock
- · President and CEO Louvet Patrice had withheld for taxes 7,875 Class A Common Stock at $387.23 (~$3.05M)
- · President and CEO Louvet Patrice had withheld for taxes 5,729 Class A Common Stock at $387.23 (~$2.22M)
- · President and CEO Louvet Patrice had withheld for taxes 1,497 Class A Common Stock at $387.23 (~$580K)
- · President and CEO Louvet Patrice had withheld for taxes 3,260 Class A Common Stock at $387.23 (~$1.26M)
- · President and CEO Louvet Patrice had withheld for taxes 852 Class A Common Stock at $387.23 (~$330K)
18-08-2026
Gores Sponsor XI LLC, AEG Holdings, LLC, and Alec Gores filed a Schedule 13G disclosing beneficial ownership of 9,120,000 Class A ordinary shares of Gores Holdings XI, Inc., representing 20.3% of the outstanding Class A shares as of July 24, 2026. The filing is a routine disclosure under Rule 13d-1(d) and does not indicate any change in control or new business combination.
- · The beneficial ownership includes 225,000 Class A ordinary shares directly held and 8,895,000 Class A shares acquirable upon conversion of Class B ordinary shares on a one-for-one basis.
- · The Class B ordinary shares automatically convert into Class A shares at the time of the Issuer's initial business combination or earlier at the holder's option.
- · The percentage ownership is based on 36,105,000 Class A ordinary shares outstanding as of July 24, 2026, as reported in the Issuer's Form 10-Q for the quarter ended June 30, 2026.
18-08-2026
Vishal Garg, CEO and founder of Better Home & Finance Holding Co, filed an amended Schedule 13D/A on August 18, 2026, disclosing beneficial ownership of 2,029,224 shares of Class A Common Stock, representing 13.7% of the outstanding shares as of July 31, 2026. The filing reveals that Garg and other reporting persons attempted to remove five directors via written consents on August 17, 2026, but the effort failed due to an administrative error, and they have since disbanded that effort; however, they simultaneously filed a preliminary consent statement to commence a formal solicitation for the same director removals. On August 18, 2026, the company filed a lawsuit against Garg in the U.S. District Court for the Southern District of New York, alleging violations of SEC reporting and proxy solicitation rules, including failure to disclose a stockholder group and making false/misleading statements, which Garg believes are without merit and intends to defend vigorously.
- · Garg's beneficial ownership includes shares held directly, via conversion of Class B Common Stock, options, and shares held by entities he controls (1/0 Real Estate, LLC and The 718 4Ever Trust I).
- · The failed consent effort on August 17 was due to an administrative error based on information provided by the Issuer's in-house Securities and Regulatory Counsel.
- · The company's lawsuit seeks a temporary restraining order and preliminary injunction against Garg, requiring corrective filings and voiding any consents/proxies obtained unlawfully.
18-08-2026
President and CEO Papapostolou Ted was awarded 33,242 Deferred Depositary Units.
- · President and CEO Papapostolou Ted was awarded 33,242 Deferred Depositary Units
18-08-2026
Chief Operating Officer Ranftl Robert P. had withheld for taxes 913 Class A Common Stock at $387.23 (~$354K). 4 transactions reported in total. Ranftl Robert P. holds 10,162 shares after the transaction.
- · Chief Operating Officer Ranftl Robert P. was awarded 2,904 Class A Common Stock
- · Chief Operating Officer Ranftl Robert P. had withheld for taxes 913 Class A Common Stock at $387.23 (~$354K)
- · Chief Operating Officer Ranftl Robert P. had withheld for taxes 775 Class A Common Stock at $387.23 (~$300K)
- · Chief Operating Officer Ranftl Robert P. had withheld for taxes 567 Class A Common Stock at $387.23 (~$220K)
18-08-2026
EVP, Pres. & CEO, BGS Raymond David Christopher gifted 907 Common Stock. Raymond David Christopher holds 41,450.495 shares after the transaction.
- · EVP, Pres. & CEO, BGS Raymond David Christopher gifted 907 Common Stock
18-08-2026
Chief Technology Officer Dickman Thomas J sold 1,922 Common Stock at $0.46 (~$878). Dickman Thomas J holds 536,707 shares after the transaction.
- · Chief Technology Officer Dickman Thomas J sold 1,922 Common Stock at $0.46 (~$878)
- · Chief Technology Officer Dickman Thomas J sold 962 Common Stock at $0.46 (~$440)
18-08-2026
Chief Executive Officer Corrigan Catherine sold 1,707 Common Stock at $66.28 (~$113K). Corrigan Catherine holds 129,108 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Executive Officer Corrigan Catherine sold 1,707 Common Stock at $66.28 (~$113K)
18-08-2026
Chief Financial Officer Flint Robert disposed to the issuer 20,486 Depositary Units at $7.88 (~$161K). 5 transactions reported in total. Flint Robert holds 20,486 shares after the transaction.
- · Chief Financial Officer Flint Robert exercised/converted 20,486 Depositary Units
- · Chief Financial Officer Flint Robert disposed to the issuer 20,486 Depositary Units at $7.88 (~$161K)
- · Chief Financial Officer Flint Robert exercised/converted 20,486 Deferred Depositary Units
- · Chief Financial Officer Flint Robert disposed to the issuer 22,610 Deferred Depositary Units
- · Chief Financial Officer Flint Robert was awarded 6,648 Deferred Depositary Units
18-08-2026
Director Koss Jennifer G. was awarded 502 Common stock, $0.0001 par value at $9.96 (~$5K). Koss Jennifer G. holds 73,269 shares after the transaction.
- · Director Koss Jennifer G. was awarded 492 Common stock, $0.0001 par value at $10.15 (~$4.99K)
- · Director Koss Jennifer G. was awarded 502 Common stock, $0.0001 par value at $9.96 (~$5K)
- · Director Koss Jennifer G. was awarded 8,032 Common stock, $0.0001 par value
18-08-2026
Director Schocken Joseph L was awarded 30,000 Stock Option (Right to Buy).
- · Director Schocken Joseph L was awarded 30,000 Stock Option (Right to Buy)
19-08-2026
On July 22, 2026, First Choice Healthcare Solutions (FCHS) entered an Amended and Restated Stock Purchase Agreement to acquire all equity of Pointe Medical Services, Pointe Med Pharmacy, Livewell MD, and Live Well Drugstore (Trulife Pharmacy) for a maximum purchase price of $21.306 million. The acquisition is tied to a separate Business Combination with Westin Acquisition Corp. and PubCo, where $6.0 million of the consideration is payable in PubCo stock and the deal is conditioned on the Business Combination closing. $300,000 in non-refundable advances have already been paid, but the transaction has not yet closed and remains subject to multiple conditions, including regulatory approvals and the absence of material adverse changes.
- · The Stock Purchase Agreement supersedes the earlier agreement from July 20, 2023, as amended.
- · Acquisition Closing is conditioned upon the consummation of the Business Combination with Westin, the effectiveness of the Registration Statement, and the availability of financings contemplated by the Business Combination Agreement.
- · Deferred cash payment of $3M is due the earlier of 45 days post-ELOC registration effective date or 90 days post-closing; accelerates upon $10M+ gross proceeds from ELOC equity sales.
- · The Deferred Cash Payment is non-interest bearing before default, then bears interest at the lesser of 12% per annum or the legal maximum.
- · Assumed Indebtedness of ~$4.306M must be repaid, refinanced, or discharged within 120 days of closing.
- · Equity Consideration has a make-good provision: if realized value is less than $3.5M at the Measurement Date (earliest of effective registration, Rule 144 eligibility, or 180 days post-closing), additional PubCo shares up to 4.999% of outstanding shares are issued; any shortfall beyond that cap is paid in cash within 30 days.
- · Performance Bonus of $1M payable by PubCo if Acquired Companies' consolidated EBITDA for the four quarters post-closing equals or exceeds 130% of EBITDA for the four quarters pre-closing.
- · Purchase Price is subject to working capital adjustment based on net working capital target of $0 at closing.
- · All Live Well Minority Members have executed joinders to the Minority Holder Agreement, so full $2.5M Minority Stock Consideration is allocable to them.
- · Closing conditions include accuracy of reps and warranties, required governmental and third-party consents, no material adverse effect on Acquired Companies since July 22, 2026, and written consent of the Live Well Drugstore manager.
19-08-2026
Lufax Holding Ltd filed a Form 6-K with the SEC on August 19, 2026, reporting its interim results for the six months ended June 30, 2026. The filing includes an announcement with The Stock Exchange of Hong Kong Limited regarding the interim results. No specific financial figures are provided in the filing itself, only the reference to the attached exhibit.
- · The filing is a Form 6-K for the month of August 2026.
- · The interim results cover the six months ended June 30, 2026.
- · The filing was signed by CEO Xiang Ji on August 19, 2026.
19-08-2026
ZTO Express (Cayman) Inc. filed a Form 6-K on August 19, 2026, reporting its second quarter 2026 unaudited financial results. The filing includes an interim results announcement for the six months ended June 30, 2026. The report was signed by CFO Huiping Yan.
- · Filing date: August 19, 2026
- · Commission File Number: 001-37922
- · Address: Building One, No. 1685 Huazhi Road, Qingpu District, Shanghai, 201708, People's Republic of China
19-08-2026
Equinor ASA disclosed a daily buyback transaction on August 14, 2026, repurchasing 415,000 shares at a weighted average price of NOK 382.7682 per share, for a total transaction value of NOK 158,848,803. This brings the total buybacks under the programme to 3,399,081 shares at an average price of NOK 336.5166, with an aggregate value of NOK 1,413,847,326. The buyback is part of a previously announced share repurchase programme.
- · Weighted average share price on August 14, 2026: NOK 382.7682
- · Previously disclosed accumulated average price: NOK 330.0844
- · Overall programme average price: NOK 336.5166
19-08-2026
Weibo Corporation filed a Form 6-K with the SEC on August 19, 2026, announcing its financial results for the second quarter ended June 30, 2026. The filing includes a press release (Exhibit 99.1) detailing the company's performance. No specific financial figures or comparisons are provided in the filing itself, so a balanced assessment of performance cannot be made from this document alone.
- · The filing is a Form 6-K for the month of August 2026.
- · The press release regarding Q2 2026 financial results was issued on August 19, 2026.
- · The company's principal executive offices are located at 8/F, QIHAO Plaza, No. 8 Xinyuan S. Road, Chaoyang District, Beijing, China.
19-08-2026
iQIYI, Inc. filed a Form 6-K with the SEC on August 19, 2026, attaching a press release announcing its second quarter 2026 financial results. The filing is signed by CFO Ying Tian. No specific financial figures are included in the 6-K itself, only a reference to the attached press release.
- · The filing is a Form 6-K for the month of August 2026.
- · Commission File Number: 001-38431.
- · The press release is attached as Exhibit 99.1.
- · The company's principal executive offices are in Beijing, China.
19-08-2026
Datavault AI Inc. entered into a Securities Purchase Agreement with Streeterville Capital, LLC on August 18, 2026, issuing a $25.03 million convertible promissory note and 15 million pre-delivery common shares. The company received $25 million in net proceeds from the note sale plus $1,500 for the pre-delivery shares, with $30,000 in transaction expenses added to the note's principal. The agreement includes covenants restricting the company from making certain issuances without investor consent and requiring continued SEC reporting and exchange listing.
- · The convertible note has a par value of $0.0001 per common share.
- · The closing date was August 18, 2026, with closing deemed to occur at Capital Law Partners PLLC in Lehi, Utah.
- · Company covenants include maintaining listing on NYSE, NYSE American, or Nasdaq; avoiding trading halts or zero bid; and not making restricted issuances without investor consent, with exceptions for Exempt Strategic Transactions involving Helmex Financial LLP, Helmex Global LLP, NYIAX, Inc., or BankWyse.
- · Company must file a Form 8-K disclosing the transactions within four trading days of the closing date.
- · Investor is an accredited investor under Rule 501(a) of Regulation D.
- · Company represents it is not a shell company and has not had shell company status in the prior 12 months.
19-08-2026
CXApp Inc. (CXAI) filed an amendment to its 8-K regarding the acquisition of Virtus Digital Marketing Pty Ltd (EngineRoom) by its subsidiary CXAI Australia. After completing acquisition accounting and updated valuation, the company determined the transaction does not meet SEC quantitative significance thresholds, so separate historical financial statements and pro forma information will not be filed. The acquisition closed on June 3, 2026, and EngineRoom's post-acquisition results are included in CXAI's consolidated financials for the quarter ended June 30, 2026.
- · The acquisition closed on June 3, 2026.
- · EngineRoom's financial results from the acquisition date are included in CXAI's unaudited condensed consolidated financial statements for the quarter ended June 30, 2026.
- · The determination regarding significance thresholds does not change the terms of the transaction, CXAI's ownership of EngineRoom, or the strategic rationale for integration.
19-08-2026
Kingsoft Cloud Holdings Limited filed a Form 6-K with the SEC on August 19, 2026, announcing its interim results for the six months ended June 30, 2026. The filing includes an announcement as Exhibit 99.1. No specific financial figures or performance metrics are provided in the cover filing itself.
- · The filing is a Form 6-K for the month of August 2026.
- · The interim results cover the six months ended June 30, 2026.
- · The announcement is attached as Exhibit 99.1.
19-08-2026
Kenon Holdings Ltd. announced receipt of approximately $93 million in connection with the payment of an arbitration award by the Republic of Peru. This represents a significant cash inflow for the company and resolves a legal proceeding in its favor. No other financial or operational metrics were provided in this brief filing.
- · Payment originates from an arbitration award against the Republic of Peru.
- · No additional details about the underlying arbitration or its timeline were disclosed.
- · The filing provides only this single event; no other financial results or operational updates were included.
19-08-2026
Kingsoft Cloud Holdings Ltd announced its unaudited second quarter 2026 financial results in a press release filed as a Form 6-K with the SEC on August 19, 2026. The filing itself does not contain the financial data, only the cover page and exhibit index referencing the press release.
- · Filing is a Form 6-K for the month of August 2026.
- · Commission file number: 001-39278.
- · Principal executive offices address: Building D, Xiaomi Science and Technology Park, No. 33 Xierqi Middle Road, Haidian District, Beijing, 100085, China.
- · The registrant files annual reports under Form 20-F.
- · Exhibit 99.1 is the press release containing the actual financial results, which is not included in this analysis.
19-08-2026
EDAP TMS SA announced the full exercise of the underwriters' option to purchase an additional 1,263,750 ADSs in its public offering, which closed on August 14, 2026. The additional issuance is expected to close on August 19, 2026, generating net proceeds of approximately $5.6 million. This follows the initial offering of 8,425,000 ADSs at $4.75 per ADS.
- · The underwriters' option was fully exercised on August 14, 2026.
- · The option allowed purchase of up to an additional 1,263,750 ADSs within 30 days.
- · The opinion of Jones Day regarding the validity of the Ordinary Shares and Additional ADSs was filed as Exhibit 5.1.
19-08-2026
Forte Biosciences, Inc. filed Amendment No. 1 to its Schedule 14D-9, disclosing that the HSR Act waiting period for argenx BV's tender offer to acquire all outstanding shares of Forte at $77.00 per share expired on August 18, 2026. This satisfies a key condition to the offer, moving the acquisition closer to completion.
- · The HSR Act waiting period expired at 11:59 p.m., Eastern Time, on August 18, 2026.
- · The Premerger Notification and Report Form was filed with the FTC and Antitrust Division on August 3, 2026.
- · The condition set forth in clause (e)(i) of Annex I to the Merger Agreement has been satisfied.
19-08-2026
Duolingo disclosed that on August 18, 2026, during an investor meeting, a screen inadvertently displayed an estimated DAU growth rate of 27.4% on August 17, 2026, relative to the prior year, with similar growth rates for previous days in August. The company cautioned that this preliminary data has not been fully reviewed or validated and should not be taken as indicative of Q3 2026 or future results. Duolingo reiterated its most recent guidance from its Q2 2026 shareholder letter and stated it does not intend to provide additional or updated guidance at this time.
- · The inadvertent disclosure occurred during an in-person meeting with certain investors at the company's offices.
- · Similar estimated growth rates were observed for previous days in August 2026.
- · The company has not completed its normal review and validation of the preliminary internal data.
- · Duolingo's most recent guidance is from its Q2 2026 shareholder letter dated August 5, 2026.
- · The company is not providing any additional or updated guidance at this time.
19-08-2026
JBS N.V. submitted a non-binding proposal to acquire the remaining ~18% of Pilgrim's Pride Corporation (PPC) it does not already own, offering a fixed exchange ratio of 2.086 JBS Class A common shares per PPC share. Based on closing prices on August 18, 2026, the implied value per PPC share was approximately $28.49, representing no premium to the market price. The proposal is subject to approval by a special committee of independent PPC directors and a majority vote of minority PPC shareholders, and there is no guarantee a binding agreement will be reached.
- · The proposal is non-binding and JBS reserves the right to withdraw or modify it at any time.
- · JBS has no interest in selling its current PPC stake or supporting an alternative change of control transaction.
- · The proposal is not subject to a due diligence condition and does not require JBS shareholder approval.
- · JBS's Board of Directors unanimously authorized the submission of the proposal.
- · The proposal requires approval by a special committee of independent PPC directors and a majority of minority PPC shares voted.
19-08-2026
News Corp filed an 8-K on August 19, 2026, disclosing daily repurchase transaction data provided to the Australian Securities Exchange (ASX) under its existing stock repurchase program. The program authorizes up to $1 billion in aggregate share repurchases of Class A and Class B common stock. The filing is a routine procedural disclosure and does not report any specific new repurchase activity or financial results.
- · The filing is made under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) of Form 8-K.
- · Exhibits 99.1 and 99.2 contain the information provided to the ASX on the respective dates noted therein.
- · The repurchase program is subject to changes in market price, general market conditions, securities laws, and alternative investment opportunities.
19-08-2026
Skye Bioscience, Inc. received a Nasdaq delisting notice on August 18, 2026, because its stockholders' equity was negative ($497,307), falling short of the $2,500,000 minimum required by Listing Rule 5550(b)(1). The company has 45 days (until October 2, 2026) to submit a compliance plan; if accepted, Nasdaq may grant an extension until February 14, 2027. While the stock continues trading under 'SKYE' for now, the company faces significant risk of delisting and is concurrently pursuing the acquisition of Redx Pharma Limited.
- · The delisting notice is based on the company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.
- · The company is also pursuing the acquisition of Redx Pharma Limited, which may be relevant to its compliance plan.
- · If the compliance plan is not accepted, the company has the right to appeal, and the stock would remain listed until the appeal process is completed.
- · There is no assurance that the company will be able to regain compliance or maintain compliance with other listing requirements.
19-08-2026
On August 13, 2026, Collective Acquisition Corp. (formerly Dune Acquisition Corp II) issued 3,500,000 Class A ordinary shares to its sponsor, Collective Acquisition Sponsor LLC, upon conversion of an equal number of Class B ordinary shares. No consideration was paid for the conversion, and the shares remain subject to the same restrictions as the Class B shares. Following the conversion, the company has 5,119,501 Class A ordinary shares and 2,250,000 Class B ordinary shares outstanding.
- · The conversion was exempt from registration under Section 3(a)(9) of the Securities Act.
- · The Class A shares issued are subject to transfer restrictions, waiver of redemption rights, and an obligation to vote in favor of a business combination.
- · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Pre-Market SEC Filings Roundup
🇺🇸 More from United States
View all →August 12, 2026
USA Corporate Events Calendar — August 12, 2026
USA Corporate Events Calendar
August 12, 2026
USA Earnings Calls Schedule — August 12, 2026
USA Earnings Calls Schedule
August 11, 2026
USA Corporate Events Calendar — August 11, 2026
USA Corporate Events Calendar
August 11, 2026
USA Earnings Calls Schedule — August 11, 2026
USA Earnings Calls Schedule